Verastem Shares Up After Mizuho Turns Bullish

By Dean Seal

Shares of Verastem are trading higher after the company’s recent update on its ovarian cancer treatment turned Mizuho analysts bullish on the stock.

The stock is up 13% at $10.53 in early trading. Shares have more than doubled since the start of the year but are still trading lower than they were a year ago.